Search details
1.
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.
J Transl Med
; 17(1): 296, 2019 08 29.
Article
in English
| MEDLINE | ID: mdl-31464635
2.
Cyclophosphamide with or without fluorouracil followed by subcutaneous or intravenous interleukin-2 use in solid tumors: A feasibility off-label experience.
Cytokine
; 113: 50-60, 2019 01.
Article
in English
| MEDLINE | ID: mdl-29958796
3.
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.
BJU Int
; 123(1): 98-105, 2019 01.
Article
in English
| MEDLINE | ID: mdl-29956884
4.
Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program.
Future Oncol
; 14(14): 1347-1354, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29774766
5.
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial.
Gynecol Oncol
; 144(2): 256-259, 2017 Feb.
Article
in English
| MEDLINE | ID: mdl-27993479
6.
Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.
Int J Mol Sci
; 19(1)2017 12 23.
Article
in English
| MEDLINE | ID: mdl-29295527
7.
Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.
Future Oncol
; 12(4): 493-502, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26776493
8.
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines.
Int J Cancer
; 137(12): 2971-80, 2015 Dec 15.
Article
in English
| MEDLINE | ID: mdl-26099996
9.
Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.
Oncology
; 88(5): 273-80, 2015.
Article
in English
| MEDLINE | ID: mdl-25592399
10.
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme.
BJU Int
; 115(5): 764-71, 2015 May.
Article
in English
| MEDLINE | ID: mdl-24988879
11.
Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients.
Future Oncol
; 11(6): 965-73, 2015.
Article
in English
| MEDLINE | ID: mdl-25760977
12.
Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.
Future Oncol
; 11(21): 2881-91, 2015.
Article
in English
| MEDLINE | ID: mdl-26436290
13.
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting.
Future Oncol
; 10(10): 1741-50, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24641206
14.
Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients.
Int J Clin Oncol
; 18(3): 510-6, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-22669361
15.
Current Trends in Mucosal Melanomas: An Overview.
Cancers (Basel)
; 15(5)2023 Feb 21.
Article
in English
| MEDLINE | ID: mdl-36900152
16.
Outcomes in patients with BRAFV600-mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib.
Tumori
; 109(6): 537-545, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37417313
17.
Concomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication.
J Immunother
; 46(1): 22-26, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-36472582
18.
Epidermotropic progression of melanoma during therapy with vemurafenib and trametinib.
J Am Acad Dermatol
; 75(4): e133-e135, 2016 Oct.
Article
in English
| MEDLINE | ID: mdl-27646754
19.
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy).
Target Oncol
; 16(6): 789-799, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34755244
20.
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without 223Ra.
Cancer Biother Radiopharm
; 36(5): 391-396, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33769088